Example: marketing
IN THIS ISSUE
Highmark Blue Shield has established preferred product for rituximab. The preferred product for rheumatoid arthritis (RA) indications is rituximab- pvvr (Ruxience) when the clinical criteria within the policy are met. This revised Medical Policy will apply to professional providers and facility claims. The effective date is April 1, 2022.
Download IN THIS ISSUE
Information
Domain:
Source:
Link to this page: